Compound Detail
CHEMBL202912
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL202912 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | UOVWMDHXSJAEOA-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
326.1
MW (Da)
-0.58
ALogP
5
HBA
2
HBD
84.3
PSA (Ų)
0.57
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 2 meas. best 4.51
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Hepatitis B virus CHEMBL613497 | EC50 | 4.51 | 4.51 | 30600.0 | 1 |
| Duck hepatitis B virus CHEMBL613761 | EC50 | 4.51 | 4.51 | 30600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Duck hepatitis B virus | EC50 | = | 30600.0 | nM | 4.51 | Inhibition of duck HBV transfected in primary duck hepatocytes | 16539393 |
| Hepatitis B virus | EC50 | = | 30600.0 | nM | 4.51 | Inhibition of wild type HBV transfected in human hepatoblastoma 2.2.15 cells | 16539393 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 16539393 | 10.1021/jm058271d | Hepatitis B virus | 4 |
| 16539393 | 10.1021/jm058271d | Duck hepatitis B virus | 2 |
| 16539393 | 10.1021/jm058271d | HepG2 | 1 |
| 16539393 | 10.1021/jm058271d | Vero | 1 |
Data from ChEMBL 36 via Core Engine